Viewing Study NCT02913456


Ignite Creation Date: 2025-12-24 @ 11:34 PM
Ignite Modification Date: 2026-04-17 @ 12:57 AM
Study NCT ID: NCT02913456
Status: COMPLETED
Last Update Posted: 2024-03-06
First Post: 2016-09-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A European Registry Study to Prospectively Observe Treatment Patterns and Outcomes in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced (LA) or Metastatic Breast Cancer (mBC) (SAMANTHA)
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module